1. Home
  2. AGYS vs RGC Comparison

AGYS vs RGC Comparison

Compare AGYS & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilysys Inc.

AGYS

Agilysys Inc.

HOLD

Current Price

$120.55

Market Cap

3.4B

Sector

Technology

ML Signal

HOLD

Logo Regencell Bioscience Holdings Limited

RGC

Regencell Bioscience Holdings Limited

HOLD

Current Price

$7.74

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGYS
RGC
Founded
1963
2014
Country
United States
Hong Kong
Employees
2413
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
AGYS
RGC
Price
$120.55
$7.74
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $134.50
N/A
AVG Volume (30 Days)
214.8K
★ 302.2K
Earning Date
10-26-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 67.07
N/A
EPS
★ 0.32
N/A
Revenue
★ $319,312,000.00
N/A
Revenue This Year
$16.13
N/A
Revenue Next Year
$16.93
N/A
P/E Ratio
$373.94
★ N/A
Revenue Growth
★ 15.85
N/A
52 Week Low
$61.50
$4.51
52 Week High
$144.82
$69.00

Technical Indicators

Market Signals
Indicator
AGYS
RGC
Relative Strength Index (RSI) 70.78 47.90
Support Level $103.53 $4.97
Resistance Level $121.59 $29.26
Average True Range (ATR) 3.84 1.37
MACD 2.01 0.07
Stochastic Oscillator 93.30 18.33

Price Performance

Historical Comparison
AGYS
RGC

About AGYS Agilysys Inc.

Agilysys Inc is engaged in hospitality software, delivering cloud-native SaaS and on-premise solutions for hotels, multi-amenity resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The Company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It operates across the Americas, Europe, the Middle East, Africa, Asia-Pacific, and India with headquarters located in Alpharetta, GA. The Company has one reportable segment serving the global hospitality industry.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: